comparemela.com

Latest Breaking News On - Zheng huangfang - Page 1 : comparemela.com

National Cancer Centre Singapore trial to evaluate benefits of TCM on cancer survivors quality of life

National Cancer Centre Singapore trial to evaluate benefits of TCM on cancer survivors quality of life Toggle share menu Advertisement Advertisement Singapore National Cancer Centre Singapore trial to evaluate benefits of TCM on cancer survivors quality of life Malt and wolfberry are some of the herbs used in the trial conducted at the National Cancer Centre Singapore. (Photo: Singapore Thong Chai Medical Institution) 22 Apr 2021 04:10PM) Share this content Bookmark SINGAPORE: Would patients who suffer from cancer-related fatigue benefit from traditional Chinese medicine (TCM)? That is the question the National Cancer Centre Singapore is trying to answer through a first-time trial involving TCM to treat the side effects of cancer. 

NCCS starts clinical trial to examine the use of TCM in countering cancer-related symptoms

NCCS starts clinical trial to examine the use of TCM in countering cancer-related symptoms The National Cancer Centre Singapore (NCCS) has started a clinical trial to examine the use of Traditional Chinese Medicine (TCM) in countering cancer-related symptoms or side effects of cancer treatment to improve cancer survivors quality of life. With advances in cancer diagnosis and treatment, cancer survivorship has improved significantly, but cancer survivors often experience a range of cancer-related and post-treatment side effects such as cancer-related fatigue. Cancer-related fatigue (CRF) refers to a distressing and persistent sense of physical, emotional and/or cognitive tiredness which is a side-effect of cancer or anti-cancer treatments. CRF is frequently experienced by cancer survivors and can interfere with their daily functioning. The HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing CRF using TraditionAL Chinese Medicine, or the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.